Critical Path for Alzheimer's Disease
- gaaindata.org
Updated Sep 20, 2018
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteSudhir Sivakumaran, PhD, Vice President, Neuroscience Program; Executive Director, CPAD (2018). Critical Path for Alzheimer's Disease [Dataset]. https://www.gaaindata.org/partner/CPADDataset updatedSep 20, 2018AuthorsSudhir Sivakumaran, PhD, Vice President, Neuroscience Program; Executive Director, CPADArea coveredDescriptionThe Critical Path for Alzheimer's Disease (CPAD: http://c-path.org/programs/cpad/) CODR data base contains patient-level control arm data (6,500 patients; 24 clinical trials; MCI and AD), fully anonymized and remapped using CDISC SDTM v3.1.2 Standard. The database includes, but is not limited to, demographic information, APOE4 genotype, concomitant medications and cognitive scales (MMSE, ADAS-Cog, CDR-SB). Currently no AD fluid biomarker or imaging data are included.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailCritical Path for Alzheimer's Disease
CPAD
The Critical Path for Alzheimer's Disease (CPAD: http://c-path.org/programs/cpad/) CODR data base contains patient-level control arm data (6,500 patients; 24 clinical trials; MCI and AD), fully anonymized and remapped using CDISC SDTM v3.1.2 Standard. The database includes, but is not limited to, demographic information, APOE4 genotype, concomitant medications and cognitive scales (MMSE, ADAS-Cog, CDR-SB). Currently no AD fluid biomarker or imaging data are included.